Laboratory assistant
REIMAGINING WHAT’S POSSIBLE IN BIOPHARMA
REIMAGINING WHAT’S POSSIBLE IN BIOPHARMA

Developing Tomorrow’s Therapies with Speed, Impact, and Purpose

Developing Tomorrow’s Therapies with Speed, Impact, and Purpose

VivaMed BioPharma is advancing drug development to deliver high-impact therapies for urgent health needs, such as pain, addiction, neurodegeneration, and rare diseases. We combine artificial intelligence, global partnerships, and decades of clinical and operational experience to bring better treatments to the people who need them most.

VivaMed BioPharma is advancing drug development to deliver high-impact therapies for urgent health needs, such as pain, addiction, neurodegeneration, and rare diseases. We combine artificial intelligence, global partnerships, and decades of clinical and operational experience to bring better treatments to the people who need them most.

Explore Our Pipeline

Explore Our Pipeline

Partner With Us

Partner With Us

An Engineered Model for Lower-Risk, Faster-to-Market Drug Development

An Engineered Model for Lower-Risk, Faster-to-Market Drug Development

About Us

At VivaMed, we combine regulatory expertise, AI-assisted modeling, and a strategically balanced portfolio of new and repurposed drug assets. This approach lets us identify high-potential therapies early, reduce attrition through smarter development, and scale innovation without the timelines and capital demands of traditional pharma models.

At VivaMed, we combine regulatory expertise, AI-assisted modeling, and a strategically balanced portfolio of new and repurposed drug assets. This approach lets us identify high-potential therapies early, reduce attrition through smarter development, and scale innovation without the timelines and capital demands of traditional pharma models.

About Us

About Us

OUR PILLARS OF INNOVATION

How We De-Risk, Accelerate, and Advance What Matters

Icon

De-Risked and Diversified

We manage a global portfolio of new and repurposed drug assets across multiple therapeutic areas and development stages—reducing risk while expanding opportunity and impact.

Our Portfolio

Icon

De-Risked and Diversified

We manage a global portfolio of new and repurposed drug assets across multiple therapeutic areas and development stages—reducing risk while expanding opportunity and impact.

Our Portfolio

Icon

AI at Every Stage

Our proprietary AI platform accelerates discovery, predicts safety and efficacy, and automates IP and regulatory drafting—cutting time and cost from preclinical to commercialization.

About Us

Icon

AI at Every Stage

Our proprietary AI platform accelerates discovery, predicts safety and efficacy, and automates IP and regulatory drafting—cutting time and cost from preclinical to commercialization.

About Us

Icon

Partnering for Progress

With over 30 academic and industry partners across 13 countries, we collaborate with world-class researchers to identify breakthroughs early and bring them to life faster.

Partnerships

Icon

Partnering for Progress

With over 30 academic and industry partners across 13 countries, we collaborate with world-class researchers to identify breakthroughs early and bring them to life faster.

Partnerships

STRATEGIC FOCUS, REAL-WORLD IMPACT

STRATEGIC FOCUS, REAL-WORLD IMPACT

We’re not chasing pipelines. We’re fixing what’s broken.

We’re not chasing pipelines. We’re fixing what’s broken.

Our Pipleline

Neurodegeneration

Pain & Anesthesia

Addiction & PTSD

Rare Diseases

Respiratory

Millions Are Slipping Through the Cracks

Mild Cognitive Impairment and Alzheimer’s affect tens of millions worldwide. Most options are too late—or too weak. We focus on early-stage neuroplasticity therapies designed to slow decline before it becomes irreversible.

Neurodegeneration

Neurodegeneration

Pain & Anesthesia

Addiction & PTSD

Rare Diseases

Respiratory

Millions Are Slipping Through the Cracks

Mild Cognitive Impairment and Alzheimer’s affect tens of millions worldwide. Most options are too late—or too weak. We focus on early-stage neuroplasticity therapies designed to slow decline before it becomes irreversible.

Neurodegeneration

Neurodegeneration

Pain & Anesthesia

Addiction & PTSD

Rare Diseases

Respiratory

Millions Are Slipping Through the Cracks

Mild Cognitive Impairment and Alzheimer’s affect tens of millions worldwide. Most options are too late—or too weak. We focus on early-stage neuroplasticity therapies designed to slow decline before it becomes irreversible.

Breakthroughs Don’t Happen Alone

Breakthroughs Don’t Happen Alone

At VivaMed, partnerships are core to how we operate—and why we succeed. We collaborate with over 30 academic institutions, biotech innovators, and clinical research teams across 13 countries. These relationships help us identify promising science early, accelerate development, and bring high-need therapies to market with precision and speed. Whether you're a research institution, technology company, or mission-aligned investor—there’s a place for you in what we’re building.

30+ university and research partners

Collaborations across 13 countries

Early access to breakthrough compounds and clinical programs

Laboratory assistant
Laboratory assistant
Laboratory assistant
Laboratory assistant
Laboratory assistant
Laboratory assistant

MOMENTUM

MOMENTUM

Proven Execution Across Programs, Platforms, and Partners

Proven Execution Across Programs, Platforms, and Partners

With decades of combined experience and a globally distributed model, VivaMed has the infrastructure, expertise, and momentum to bring high-impact therapies to life—efficiently and at scale.

With decades of combined experience and a globally distributed model, VivaMed has the infrastructure, expertise, and momentum to bring high-impact therapies to life—efficiently and at scale.

150+ drug assets licensed or developed

39 regulatory approvals supported

Offices in 5 countries across 3 continents

Our Partnerships

Our Partnerships

TEAM

TEAM

From Clinical Trials to Company Exits—We’ve Done This Before

From Clinical Trials to Company Exits—We’ve Done This Before

Our leadership team combines deep clinical, technical, and operational expertise with a track record of real outcomes. We’ve launched biotech startups, led drug approvals, built AI platforms, and guided exits worth hundreds of millions. Now we’re applying that experience to fix what’s broken in drug development—and deliver therapies that matter.

Our leadership team combines deep clinical, technical, and operational expertise with a track record of real outcomes. We’ve launched biotech startups, led drug approvals, built AI platforms, and guided exits worth hundreds of millions. Now we’re applying that experience to fix what’s broken in drug development—and deliver therapies that matter.

Meet the Team

Meet the Team

40+

40+

Years as Healthcare Entrepreneurs Scaling Startups

25+

25+

Years Partnering with Research Universities, Companies, and Private Equity

Laboratory assistant
Laboratory assistant
Laboratory assistant

Global. Agile. Mission-Aligned.

We’re not here to theorize—we’re here to deliver.

Laboratory assistant
Laboratory assistant

CONTACT

CONTACT

Let's Connect

Let's Connect

Have a question, opportunity, or idea? Whether you're a researcher, investor, or potential partner—we’d love to hear from you.

Have a question, opportunity, or idea? Whether you're a researcher, investor, or potential partner—we’d love to hear from you.